After-Hours Stock Movers 02/17: (SNBR) (TLRY) (WK) Higher; (IMBI) (STMP) (SPWR) Lower (more...)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
CLSA Reiterates Underperform (4) Rating on iQIYI (IQ), Notes Weak Q1 2021 Guidance
February 18, 2021 9:40 AM ESTCLSA analyst Elinor Leung reiterated an Underperform (4) rating and $25.50 price target on iQIYI (NASDAQ: IQ)
The analyst comments "iQiYi 4Q20 results were in-line but weak. Total revenue fell 0.5% YoY to Rmb7.5bn as paying users declined 4% YoY to 101m given a lack of quality... More
Tilray (TLRY) PT Raised to $25 at Roth Capital
February 18, 2021 9:37 AM ESTRoth Capital analyst Scott Fortune raised the price target on Tilray (NASDAQ: TLRY) to $25.00 (from $10.00) while maintaining a Neutral rating.
The analyst comments "TLRY reported a strong quarter with revenues/margins up sequentially and an increased y/y ASP to $3.72 as international... More
Twilio (TWLO) PT Raised to $500 at Needham & Company
February 18, 2021 6:25 AM ESTNeedham & Company analyst Richard Valera raised the price target on Twilio (NYSE: TWLO) to $500.00 (from $340.00) while maintaining a Buy rating.
The analyst comments "TWLO delivered strong 4Q20 results, solidly exceeding consensus (even ex-M&A), and issuing strong 1Q21 revenue guidance, albeit w/below... More
Veru, Inc. (VERU) Prices 6.45M Share Common Offering at $15.50/Sh
February 18, 2021 5:55 AM ESTVeru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of prostate and breast cancer, announced today the pricing of an underwritten public offering of 6,451,613 shares of its common stock at a price to the public of $15.50 per share. The gross proceeds to Veru from... More
SunPower (SPWR) PT Raised to $40 at Roth Capital
February 18, 2021 5:26 AM ESTRoth Capital analyst Phiilip Shen raised the price target on SunPower (NASDAQ: SPWR) to $40.00 (from $16.00) while maintaining a Buy rating.
The analyst comments "While SPWR provided mixed results/guidance, management is improving GMs, and there seems to be more ahead. Many were... More

